Grants for Special district governments - Federal

The U.S. Fish and Wildlife Service (FWS) is the premier government agency dedicated to the conservation, protection, and enhancement of fish, wildlife and plants, and their habitats. We are the only agency in the federal government whose primary responsibility is the conservation and management of these important natural resources for the American public.FWS origins date back to 1871 when Congress established the U.S. Fish Commission to study the decrease in the nations food fishes and recommend ways to reverse that decline. Today, we are a diverse and largely decentralized organization, employing about 8,000 dedicated professionals working out of facilities across the country, including a headquarters office in Falls Church, Virginia, and eight Regional offices.The National Infrastructure Partnerships initiative of the US Fish and Wildlife Service (FWS) encourages National Wildlife Refuge System field stations to partner with local, regional, and national nonprofit organizations, other land management groups, state and tribal partners, and others to accomplish projects that:i. promote the stewardship of Refuge System resources through habitat maintenance, restoration, and improvement, andii. support the operation and maintenance of the Refuge System through constructing, operating, maintaining, or improving the facilities and services of the Refuge System.The goals of the initiative are to enable local communities to play a more active role in increasing outdoor recreation opportunities on refuge lands and waters, to be more focused and deliberate in using partnerships to help FWS address infrastructure repair and improvement needs such as proactive maintenance and the maintenance backlog, and to enhance wildlife habitat.Additionally, this initiative can help address multiple FWS priorities as a catalyst for:Economic and Conservation EnhancementCareer Training and Mentoring Opportunities for Youth and AdultsEquity and Inclusion in Conservation and RecreationClimate and Wildlife ResilienceCommunity HealthSuccessful projects will address identified FWS priorities or projects at FWS sites that enhance the visitor experience, promote wildlife-dependent outdoor recreation, provide sustainable wildlife habitat, provide career training and mentoring opportunities, and engage the community in opportunities to participate in wildlife-dependent outdoor recreation on FWS lands and waters.See Full Announcement for additional eligibility requirements.

This funding opportunity supports physician-scientists with clinical doctorate degrees who are transitioning to independent research careers in non-malignant hematology, enabling them to advance their research on blood disorders.

This funding opportunity supports research projects that develop and test strategies to overcome barriers to HIV prevention for individuals who use substances, particularly focusing on marginalized groups such as women, transgender individuals, and those involved in the criminal justice system.

Notice of Funding Opportunity Summary NRCS is announcing the availability of Conservation Innovation Grants (CIG) State Program funding to stimulate the development and adoption of innovative conservation approaches and technologies. Applications are accepted from eligible entities (Section C) for projects carried out in the state of Kansas. A total of up to $250,000 is available for the Kansas CIG competition in FY 2024. All non-Foreign, non-federal entities (NFE) and individuals are invited to apply, with the sole exception of federal agencies. Projects may be between one and three years in duration. The maximum award amount for a single award in FY 2024 is $125,000. For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov. Completing all steps required to start an application can take a significant amount of time, plan accordingly. Key Dates Applicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on Friday, September 06, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts. For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed. The agency anticipates making selections by November 29, 2024, and expects to execute awards by February 01, 2025. These dates are estimates and are subject to change.

This funding opportunity supports the development of advanced bioelectronic bandages that can monitor and treat wounds in real-time, specifically targeting military medical care for combat personnel.

This grant provides funding for innovative technology development projects that aim to create new tools and methods for advancing biomedical research, focusing on prototypes that address significant technical challenges.

This funding opportunity provides up to $1.3 billion to support the development and demonstration of advanced carbon capture technologies for power generation and industrial sectors, targeting a wide range of eligible applicants including educational institutions, nonprofits, and businesses.

This funding opportunity supports U.S. higher education institutions and nonprofits in training predoctoral and postdoctoral researchers to advance interdisciplinary research on Alzheimer's Disease and related dementias.

This funding opportunity supports early-career researchers from diverse backgrounds in advancing their studies on Alzheimer's Disease-Related Dementias, helping them transition from mentored postdoctoral positions to independent faculty roles.

This funding opportunity supports conservation projects for at-risk species in the U.S. by providing financial assistance to a diverse range of applicants, including nonprofits, educational institutions, and government entities, to implement proactive measures that prevent species from needing federal protection.

This funding opportunity provides financial support to local governments, educational institutions, tribal governments, and nonprofit organizations in Colorado for projects aimed at reducing wildfire risks and enhancing community resilience against wildfires.

This grant provides funding to organizations that support programs helping older adults and individuals with disabilities manage chronic diseases while improving their behavioral health through education and community partnerships.

The "Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH)" grant aims to support research that develops new behavioral measures and data infrastructure to improve the diagnosis, prognosis, and treatment of mental disorders.

This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This NOFO will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This NOFO will not accept applications proposing a clinical trial.

Notice of Funding Opportunity Description Background The Food and Drug Administration (FDA) protects the public health by ensuring that medical products intended to be marketed in the United States are safe and effective for their intended use. FDA stakeholders are exploring innovative ways to produce scientific evidence in support of regulatory submissions, including the development of new data sources, study designs, methodologies, and technologies. FDA encourages and facilitates the use of such innovative approaches while ensuring that the scientific evidence supporting marketing approvals meet our high evidentiary standards. The Prescription Drug User Fee Act VII (PDUFA VII) commitment letter represents the product of discussions between the FDA, regulated industry, and public stakeholders, as mandated by Congress. The performance and procedural goals and other commitments specified in the PDUFA VII commitment letter apply to aspects of the human drug review program that are important for facilitating timely access to safe, effective, and innovative new medicines for patients. The commitment letter includes goals relating to the use of digital health technologies (DHTs) to support drug development and review. A DHT is a system that uses computing platforms, connectivity, software, and/or sensors, for health care and related uses. DHTs for remote data acquisition in clinical investigations can include hardware and/or software to perform one or more functions. DHTs may rely on or work with other technologies that support their operation, such as general-purpose computing platforms (e.g., smartphones) and communication networks. Among other activities relating to the use of DHTs, FDA has established a Framework for the Use of DHTs in Drug and Biological Product Development to guide the use of DHT-derived data in regulatory decision-making for drugs (hereinafter Framework ). The Framework highlights FDA’s DHT efforts including workshops and demonstration projects; engagement with stakeholders; establishment of internal processes to support the evaluation of DHTs for use in drug development; promotion of shared learning and consistency regarding DHT-based policy, procedure, and analytic tool development; and publication of guidance documents. In addition, FDA’s webpage DHTs for Drug Development (available at: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development) provides an overview of the ongoing DHT efforts, including demonstration projects. A variety of project types are welcomed under this NOFO, applicable to drugs and biologics (not devices). FDA is particularly interested in projects that evaluate the use of DHTs in drug development. Project Objectives The overarching goal of this notice of funding opportunity (NOFO) is to explore the role of DHTs (e.g., actigraphy, photography, environmental sensors) in the evaluation of new drugs. These projects may involve engagement with researchers from academia, the biopharmaceutical industry, patient groups, and other stakeholders. The objectives of these projects are to advance DHTs for clinical drug development, expand the ability to capture early manifestations of chronic diseases, determine outcomes in populations with unmet medical needs and enhance convenience for trial participants by allowing for remote data acquisition in clinical investigations. The scope includes, but is not limited to, projects that focus on: Comparing digital measurements to traditional measurements in clinical trials to evaluate drugs Developing and evaluating novel endpoints using DHTs to address unmet needs for drug clinical trials (e.g., use of environmental sensors to capture apnea in pediatric patients) Comparing metrics to evaluate continuous measurements (e.g., maximum activity and stamina) Capturing early manifestations of chronic diseases (e.g., dementia) through the use of DHTs

With this solicitation, BJA seeks to support law enforcement agencies that have an intellectual property (IP) enforcement task force or plan to create one. The Intellectual Property Enforcement Program assists state, local, and tribal jurisdictions in preventing and reducing intellectual property theft and related crime as well as supporting law enforcement in investigating and prosecuting IP crimes and reducing violent crime associated with IP cases and investigations. Any awards under this solicitation would be made under statutory authority provided by the Consolidated Appropriations Act, 2024. As of the writing of this solicitation, the Department of Justice is operating under a short-term Continuing Resolution with no full-year appropriation for the Department being enacted for FY 2024 currently. Specific Information The Intellectual Property Enforcement Program: Protecting Public Health, Safety, and the Economy from Counterfeit Goods and Product Piracy is specifically designed to support jurisdictions in investigating and prosecuting intellectual property crimes. This will be accomplished by assisting state, local, and tribal jurisdictions to build partnerships with federal agencies and prosecutors through IP enforcement task forces. This program also works to prevent and reduce intellectual property theft and related crimes by improving community and buyer awareness. IPEP includes an educational component to assist buyers in determining the authenticity of seemingly legitimate websites that instead deceive consumers into purchasing counterfeit goods. Solicitation Goals and Objectives Goals The goal of this program is to improve the coordination of IP enforcement efforts among federal, state, local, tribal, and territorial authorities. This coordination will include IP task force members and federal agencies meeting to update, discuss, and collaborate on IP investigations, prosecutions, training, and public awareness activities. The information to be shared through these task forces must include information about targeting, investigating, analyzing, and prosecuting matters involving IP crimes as they relate to violations of state and local criminal statutes and federal prosecutions. Objectives • Improve coordination of IP enforcement efforts among federal, state, local, tribal, and territorial authorities. • Establish and/or enhance state, local, tribal, or territorial IP enforcement task forces, to include campus law enforcement agencies. Deliverables • Provide information to update the United States Department of Justice’s Prioritizing Resources and Organization for Intellectual Property (PRO IP) Act Annual Report. • Provide updates to the OJP Program Plan. Page 7 O-BJA-2024-172080 For information about what the applicant needs to submit regarding Goals, Objectives, and Deliverables, please see the How to Apply section on the Application Goals, Objectives, Deliverables, and Timeline Web-Based Form. Priority Areas In order to further OJP’s mission, OJP will provide priority consideration when making award decisions to the following: The Inventory of Federal Priorities for Policing will help the U.S. Department of Justice evaluate the possibility for priority consideration, where appropriate, and identify potential gaps in training and technical assistance. To receive this additional priority consideration, applicants will complete the Inventory as a survey within JustGrants. For additional information, see the Data Requested with Application section.

This funding opportunity supports a wide range of research projects aimed at improving the understanding, prevention, diagnosis, and treatment of Alzheimer's Disease and related dementias, particularly focusing on underserved populations and health disparities.

This funding opportunity supports research partnerships between technology developers and academic researchers to optimize and evaluate digital mental health interventions, particularly for underserved populations.

This funding opportunity supports research projects aimed at developing safe and effective medications for treating substance use disorders, particularly for substances like cocaine, methamphetamine, and cannabis, and is open to a wide range of eligible institutions and organizations.

The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA